Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
CAR T-cell Therapy in Patients With Renal Dysfunction
- Status
- RECRUITING
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Delayed Tolerance Through Mixed Chimerism
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL
- Status
- TERMINATED
- Phase
- PHASE2
NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Allo HSCT Using RIC and PTCy for Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)
- Status
- UNKNOWN
- Phase
- PHASE1
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Status
- RECRUITING
- Phase
- PHASE2
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1